San Francisco, CA - endpoint, an interactive response technology (IRT) solutions provider, introduces its new clinical supply management tool DRIVE, which enables IRT functionality for non-IRT and Investigator-Sponsored Trials (IIT). DRIVE will be unveiled at the Drug Information Association (DIA) Annual Meeting, June 26-30, in Philadelphia. DRIVE delivers the benefits of IRT supplies management to the entire development program, including early-phase non-IRT and IIT, in one system - saving sponsors and sites time, reducing waste and optimizing the supply chain. Features include:
“While individual, stand-alone IRT systems for patient and supplies management are not warranted for every study, the challenge of managing supplies across IRT and non-IRT studies, including IIT, remains a sponsor pain point. To alleviate this issue, endpoint has developed DRIVE, a dynamic, easy-to-use clinical supply management hub,” said Chuck Harris, general manager. “DRIVE reflects endpoint’s commitment to addressing our industry’s challenges with novel, SaaS-based solutions.” endpoint will also be unveiling its new brand, which showcases endpoint’s services and technology by both highlighting the company’s proven expertise and emphasizing PULSE as a reliable IRT solution. Stop by Booth 501 at DIA or
schedule a meeting
to ask about endpoint’s feature-rich supply chain and clinical management tools and see how it gets
Straight to the Point
.
About endpoint
endpoint is focused primarily on providing interactive response technology (IRT) systems and solutions that support the life sciences industry. endpoint’s proprietary IRT system configuration engine, PULSE, provides non-technical users with the necessary tools to design and deploy customized IRT solutions in just four weeks. Having a team with up to 20 years of industry experience and headquartered in San Francisco, endpoint has been developing IRT systems since 2009. See how our flexible IRT solution meets the unique needs of any clinical trial at
www.endpointclinical.com
.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.